Lv1
58 积分 2025-06-04 加入
Prognostic Implications of Altered Human Epidermal Growth Factor Receptors (HERs) in Gastric Carcinomas: HER2 and HER3 Are Predictors of Poor Outcome
1个月前
已完结
[Clinical pathological expert consensus on HER2 immunohistochemical testing in urothelial carcinoma(2026 version)]
1个月前
已完结
Small cell carcinoma of the urinary bladder: a 15‐year retrospective review of treatment and survival in the Anglian Cancer Network
4个月前
已完结
Pericardial bioscaffold coated with ECM gels and urothelial cells for the repair of a rabbit urinary bladder defect
5个月前
已完结
Bladder sparing options for muscle-invasive bladder cancer
5个月前
已完结
Disitamab vedotin plus toripalimab in patients with locally advanced or metastatic urothelial carcinoma (RC48-C014): a phase Ib/II dose-escalation and dose-expansion study
6个月前
已完结
Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline
6个月前
已完结
Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical Cystectomy
6个月前
已完结
Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer
6个月前
已完结
TAR-200 plus cetrelimab versus cetrelimab monotherapy as neoadjuvant therapy in patients with muscle-invasive bladder cancer who are ineligible for or decline neoadjuvant cisplatin-based chemotherapy (SunRISe-4): interim analysis of a randomised, open-label phase 2 trial
6个月前
已完结
皖公网安备34019202002308
